GL1X · GenesisL1 explorer

Research workbench

Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human lck, activated form (auto- phosphorylated on TYR394)

Analyse Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZM4
Type
protein
Length
271 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase lck
EC
2.7.10.2
UniProt
P06239
Ligands
KSM, SO4
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase lck (EC 2.7.10.2)protein27139% helix, 20% strandP06239

Ligands and binding sites

  • KSM · N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13740.640.7939KSM

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 2ZM4 · Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human LCK… · the same entry in another collection · chain A against A, TM-score 1.00
  • P06239 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase lck (P06239) · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.